Best oncologists in Barcelona: TOP 30 doctors

• Specializes in Oncology, utilizing microsurgery and non-invasive radiosurgery techniques.
• Trained in Oncology in Sweden, Switzerland, Canada, and the USA.
• Performs over 200 Oncology-related operations annually.
• Member of European Society of Brain Tumors Neurosurgery, with a focus on Oncologic cases.
• Part of the American Academy of Minimally Invasive Spinal Medicine, with relevance to spinal tumors.
• Offers online consultations for Oncology patients, ensuring accessibility and convenience.

• Renowned Oncologist Dr. Jaume Capdevila, specializes in digestive and pancreatic cancers.
• Trained internationally, including a fellowship in Endocrine Oncology in Sweden.
• Dr. Capdevila holds a Medical Oncology specialization from Santa Creu i Sant Pau Hospital.
• Active member of EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD, and GETHI.
• Certified in Medicine and Surgery, focuses on evidence-based cancer treatments.
• Provides online consultations for patients seeking oncology expertise.

Onco-Urologist

Dr. Carlos Ballesta López is a top specialist in pancreatic cancer treatment, general and digestive surgery with 30+ years of experience. He is a pioneer in laparoscopic surgery, which reduces pain and recovery time for patients. He has performed over 12,000 operations of abdominal and digestive surgery by laparoscopy, and has organized courses of laparoscopic surgery for Spanish and foreign surgeons. He has a Bachelor of Medicine and Surgery from the University of Granada (1973), Medical specialist in General Surgery (1977) and Gastroenterology (1979), and is currently the Director of the Dr. Ballesta Laparoscopic Center.

Prof. Fermin Mearin Manrique is an experienced Spanish gastroenterologist with over 40 years of practice. He specializes in diagnostics and treatment of digestive system conditions, with a focus on functional digestive disorders management. He has extensive academic and professional experience, having written over 400 scientific works and being a member of numerous organizations.

Oncologist, Specialist in skin cancer treatment

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Radiation oncologist

Dr. Lana Bijelic is an oncological surgeon and specialist in peritoneal carcinomatosis who joined the Teknon Oncology Institute’s Carcinomatosis Surgical Group in 2019. She is certified by the American Board of Surgery and is a member of various scientific communities, including the American College of Surgeons and the Society of Surgical Oncology. She has held various research and clinical positions, and has been awarded numerous academic achievements.

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

Professor Felip is a medical doctor from the UAB who specializes in thoracic malignancy management and is responsible for thoracic cancer trials. She is a current member of various societies related to oncology and has authored many peer-reviewed articles and book chapters in the field. She is also an associate professor at the UAB and professor of medicine at the Universitat de Vic, and is involved in the training of medical students and residents.

This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.

She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).

In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.

Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.

Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.

In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.

Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.

She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.

She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).

Dr. Balaña received her medical degree from the Central University of Barcelona and completed her residency in medical oncology at one of the best public hospitals in Spain, Vall d'Hebrón Hospital.

She was a leading specialist in the treatment of brain tumors at the Institute of Oncology of Catalonia, a founding member and current president of the Spanish Neuro oncology Research Group (GEINO), and a member of the scientific committee of the European Association for Neuro-Oncology.

He is the recipient of prestigious research grants in the field of brain tumors.

Dr. Balaña is also a member of the European Society of Medical Oncology and the author of modern European protocols for the treatment of brain tumors, as well as the protocols of the Spanish Society of Medical Oncology (SEOM).

Dr. Balaña has published over 400 articles, books and scientific papers at national and international conferences.

He is the author of articles in prestigious scientific publications such as:

Lancet Oncology;

Nature Reviews in Clinical Oncology;

Clinical Cancer Research and others.

Experienced surgeon with expertise in the fields of Peritoneal Oncology, Melanoma and Sarcoma Surgery, Laparoscopic and Robotic Surgery, and Hepato-Biliary and Pancreatic Surgery. Speaker at National and International Congresses on Surgical Treatment of Advanced Abdominal and Pelvic Cancers, author and co-author of scientific publications of national and international importance, and investigator of clinical trials of oncological surgery of national and international importance. Member of national and international scientific communities.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.